bnt211
biontech
['solid tumor', 'bnt211', 'biontech']
biontech presents encouraging phase 1/2 follow-up data for car-t candidate bnt211 in hard-to-treat solid tumors at esmo 
We provide a balanced view on small cap biotech equities.